OncXerna Therapeutics
Waltham, US · Founded 2018 · Cayman Islands corporation · 5 known investors
Find your way into OncXerna Therapeutics
Sign up to see every warm intro you have to OncXerna Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OncXerna Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CB
Chrystiyna BedrijNamed on SEC filing
PB
Peter BisgaardNamed on SEC filing
VC
Vincent CheungNamed on SEC filing
LB
Laura BenjaminNamed on SEC filing
BC
Benjamin ChenNamed on SEC filing
Investors · 5
K2 HealthVentureslisted by K2 HealthVenturesBoston
How we know: K2 HealthVentures's portfolio page · Not right? Tell us
Nan Fung Life SciencesreportedHong Kong
How we know: funding news · in.marketscreener.com · Not right? Tell us
Pivotal bioVenture Partners ChinareportedShanghai
How we know: funding news · in.marketscreener.com · Not right? Tell us
Volcanics VenturereportedShanghai
How we know: funding news · in.marketscreener.com · Not right? Tell us
Also in the syndicate · 1
China Merchants Bank Co., Ltd.
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 of 2 rounds · 2018–2022
▶$30MraisedMar 2022 · 4 investors · BiotechnologyRule 506(b)
▶$30MraisedMar 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chrystiyna BedrijDirector
- Peter BisgaardDirector
- Vincent CheungDirector
- Laura BenjaminDirector
- Benjamin ChenDirector
- Offering amount
- $100M
- Amount sold
- $30M
- First sale
- Feb 2022
- Incorporated
- Corporation, Cayman Islands, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are OncXerna Therapeutics's investors?
- OncXerna Therapeutics's investors include K2 HealthVentures, Nan Fung Life Sciences, Pivotal bioVenture Partners China, Volcanics Venture.
- How much funding has OncXerna Therapeutics raised?
- OncXerna Therapeutics has disclosed $30M raised across 1 of its 2 known rounds.
- Where is OncXerna Therapeutics headquartered?
- OncXerna Therapeutics is headquartered in Waltham, US.